{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:41:54Z","timestamp":1794217314334,"version":"4.8.0"},"reference-count":28,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"UK Research and Innovation MRC","award":["MR\/P026222\/1"],"award-info":[{"award-number":["MR\/P026222\/1"]}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["Project \u2018COVIRES\u2019 (FZK: 13GW0540B)"],"award-info":[{"award-number":["Project \u2018COVIRES\u2019 (FZK: 13GW0540B)"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013281","name":"Joint Programming Initiative on Antimicrobial Resistance","doi-asserted-by":"crossref","award":["JPIAMRWG-020"],"award-info":[{"award-number":["JPIAMRWG-020"]}],"id":[{"id":"10.13039\/100013281","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2023,11,10]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Diagnostics are widely considered crucial in the fight against antimicrobial resistance (AMR), which is expected to kill 10\u2009million people annually by 2030. Nevertheless, there remains a substantial gap between the need for AMR diagnostics versus their development and implementation. To help address this problem, target product profiles (TPP) have been developed to focus developers\u2019 attention on the key aspects of AMR diagnostic tests. However, during discussion between a multisectoral working group of 51 international experts from industry, academia and healthcare, it was noted that specific AMR-related TPPs could be extended by incorporating the interdependencies between the key characteristics associated with the development of such TPPs. Subsequently, the working group identified 46 characteristics associated with six main categories (ie, Intended Use, Diagnostic Question, Test Description, Assay Protocol, Performance and Commercial). The interdependencies of these characteristics were then identified and mapped against each other to generate new insights for use by stakeholders. Specifically, it may not be possible for diagnostics developers to achieve all of the recommendations in every category of a TPP and this publication indicates how prioritising specific TPP characteristics during diagnostics development may influence (or not) a range of other TPP characteristics associated with the diagnostic. The use of such guidance, in conjunction with specific TPPs, could lead to more efficient AMR diagnostics development.<\/jats:p>","DOI":"10.1136\/bmjgh-2023-012319","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T01:05:18Z","timestamp":1702947918000},"page":"e012319","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Expert guidance on target product profile development for AMR diagnostic tests"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6121-2021","authenticated-orcid":false,"given":"Till T","family":"Bachmann","sequence":"first","affiliation":[{"name":"Center for Inflammation Research, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Mitsakakis","sequence":"additional","affiliation":[{"name":"Laboratory for MEMS Applications, IMTEK\u2013Department of Microsystems Engineering, University of Freiburg, Freiburg, Germany"},{"name":"Hahn-Schickard, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-4497","authenticated-orcid":false,"given":"John P","family":"Hays","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Centre (Erasmus MC), Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"van Belkum","sequence":"additional","affiliation":[{"name":"BioM\u00e9rieux Open Innovation & Partnerships, La Balme Les Grottes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Russom","sequence":"additional","affiliation":[{"name":"Division of Nanobiotechnology, KTH Royal Institute of Technology, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Luedke","sequence":"additional","affiliation":[{"name":"Curetis GmbH, Holzgerlingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar Skov","family":"Simonsen","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infection Control, University Hospital of North Norway, Troms\u00f8, Norway"},{"name":"Faculty of Health Sciences, UiT \u2013 The Arctic University of Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Abel","sequence":"additional","affiliation":[{"name":"Division of Pathology and Laboratory Medicine, Lahey Hospital & Medical Center, Burlington, Massachusetts, USA"},{"name":"Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-6373","authenticated-orcid":false,"given":"Harald","family":"Peter","sequence":"additional","affiliation":[{"name":"Branch Bioanalytics and Bioprocesses, Fraunhofer Institute for Cell Therapy and Immunology, Potsdam, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[{"name":"Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"},{"name":"Department of Medical Microbiology, Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Moran-Gilad","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, School of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8025-3926","authenticated-orcid":false,"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Biomedical Diagnostic Centre (CDB), Hospital Cl\u00ednic, School of Medicine, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-1341","authenticated-orcid":false,"given":"Karsten","family":"Becker","sequence":"additional","affiliation":[{"name":"University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Moons","sequence":"additional","affiliation":[{"name":"Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium"},{"name":"Department of Medical Microbiology, Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangarajan","family":"Sampath","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna W","family":"Peeling","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, London School of Hygiene and Tropical Medicine Faculty of Infectious and Tropical Diseases, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-7875","authenticated-orcid":false,"given":"Saturnino","family":"Luz","sequence":"additional","affiliation":[{"name":"Usher Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd","family":"van Staa","sequence":"additional","affiliation":[{"name":"Health eResearch Centre, Farr Institute for Health Informatics Research, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Di Gregori","sequence":"additional","affiliation":[{"name":"San Pier Damiano Hospital GVM Care and Research, Ravenna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"2025073015155496000_8.12.e012319.1","unstructured":"Global AMR R&D Hub . Estimating global patient needs and market potential for priority health technologies addressing antimicrobial resistance. 2021. Available: https:\/\/globalamrhub.org\/wp-content\/uploads\/2021\/08\/EAG-Report_FINAL_20082021.pdf [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"key":"2025073015155496000_8.12.e012319.3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000132","article-title":"Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform","volume":"1","author":"Engel","year":"2016","journal-title":"BMJ Glob Health"},{"key":"2025073015155496000_8.12.e012319.4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10096-019-03492-4","article-title":"The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex \u2018mix-and-match\u2019 implementation package","volume":"38","author":"Hays","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025073015155496000_8.12.e012319.5","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01582-1","article-title":"Target product profiles for medical tests: a systematic review of current methods","volume":"18","author":"Cocco","year":"2020","journal-title":"BMC Med"},{"key":"2025073015155496000_8.12.e012319.6","doi-asserted-by":"crossref","DOI":"10.1017\/S0266462321000374","article-title":"Integrating early economic evaluation into target product profile development for medical tests: advantages and potential applications","volume":"37","author":"Cocco","year":"2021","journal-title":"Int J Technol Assess Health Care"},{"key":"2025073015155496000_8.12.e012319.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13690-021-00708-y","article-title":"The relevance of target product profiles for manufacturers, experiences from the World Health Organization initiative for point-of-care testing for sexually transmitted infections","volume":"79","author":"Murtagh","year":"2021","journal-title":"Arch Public Health"},{"key":"2025073015155496000_8.12.e012319.8","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.287052"},{"key":"2025073015155496000_8.12.e012319.9","unstructured":"US Food and Drug Administration . Guidance for industry and review staff target product profile \u2014 a strategic development process tool. 2007. Available: https:\/\/www.federalregister.gov\/documents\/2007\/03\/30\/E7-5949\/draft-guidance-for-industry-and-review-staff-on-target-product-profile-a-strategic-development [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0098-9"},{"key":"2025073015155496000_8.12.e012319.11","unstructured":"World Health Organization . Target product profiles for antibacterial resistance diagnostics. Geneva: World Health Organization, 2020. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/331054"},{"key":"2025073015155496000_8.12.e012319.12","doi-asserted-by":"crossref","DOI":"10.1093\/oodh\/oqac001","article-title":"Development of a target product profile for a One Health antimicrobial resistance surveillance service","volume":"1","author":"Tobin","year":"2023","journal-title":"Oxford Open Digital Health"},{"key":"2025073015155496000_8.12.e012319.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161721","article-title":"Target product profile for a diagnostic assay to differentiate between bacterial and non-bacterial infections and reduce antimicrobial overuse in resource-limited settings: an expert consensus","volume":"11","author":"Dittrich","year":"2016","journal-title":"PLoS One"},{"key":"2025073015155496000_8.12.e012319.14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200531","article-title":"Matching diagnostics development to clinical need: target product profile development for a point of care test for community-acquired lower respiratory tract infection","volume":"13","author":"Gal","year":"2018","journal-title":"PLoS One"},{"key":"2025073015155496000_8.12.e012319.15","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-053071"},{"key":"2025073015155496000_8.12.e012319.16","unstructured":"Foundation for Innovative New Diagnostics (FIND) . Target product profiles. Available: https:\/\/www.finddx.org\/tools-and-resources\/rd-and-innovation\/target-product-profiles\/ [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.17","unstructured":"World Health Organization . Target product profile directory. Available: https:\/\/www.who.int\/tools\/target-product-profile-database [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.18","unstructured":"UNICEF . Supply division, target product profiles. Available: https:\/\/www.unicef.org\/supply\/target-product-profiles [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.19","unstructured":"PATH . Target product profile: point-of-care malaria plasmodium falciparum highly sensitive rapid diagnostic test. 2015. Available: https:\/\/www.path.org\/resources\/tpp-pfmalaria\/ [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.20","unstructured":"PATH . Target product profile: trachoma surveillance diagnostic - antigen lateral flow test. 2015. Available: https:\/\/www.path.org\/resources\/tpp-trachoma-antigen-lateral-flow-test [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.21","unstructured":"PATH . Diagnostics for neglected tropical diseases: defining the best tools through target product profiles. 2015. Available: https:\/\/www.path.org\/resources\/diagnostics-for-neglected-tropical-diseases-defining-the-best-tools-through-target-product-profiles [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.22","unstructured":"WHO, FIND . Consensus meeting report: development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease. Geneva: World Health Organization, 2017. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259176\/WHO-HTM-TB-2017.18-eng.pdf;jsessionid=BD8E426CA555DE9FEAB589FF2A9B2CCC?sequence=1"},{"key":"2025073015155496000_8.12.e012319.23","unstructured":"WHO, FIND . Target product profile for Zaire Ebolavirus rapid, simple test to be used in the control of the Ebola outbreak in West Africa. 2014. Available: https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/who_ebola_diagnostics_tpp_oct-2014.pdf [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.24","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303"},{"key":"2025073015155496000_8.12.e012319.25","unstructured":"Cocco P , Ayaz-Shah A , Shinkins B , et al . Methods adopted to develop a target product profile (TPP) in the field of medical tests: a systematic review. 2018. Available: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42018115133 [Accessed 1 Sep 2023]."},{"key":"2025073015155496000_8.12.e012319.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.09.018"},{"key":"2025073015155496000_8.12.e012319.27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0272989X19866415","article-title":"Early economic evaluation of diagnostic technologies: experiences of the NIHR diagnostic evidence co-operatives","volume":"39","author":"Abel","year":"2019","journal-title":"Med Decis Making"},{"key":"2025073015155496000_8.12.e012319.28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1017\/S0266462316000064","article-title":"The early bird catches the worm: early cost effectiveness analysis of new medical tests","volume":"32","author":"Buisman","year":"2016","journal-title":"Int J Technol Assess Health Care"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2023-012319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:16:06Z","timestamp":1753913766000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2023-012319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,18]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjgh-2023-012319"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2023-012319","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}